Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 4, 2007
Patent Application Number
10155514
Date Filed
May 23, 2002
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention is a method of inhibiting islet cell transplant rejection, particularly to treat diabetes, such as type-1 and type-2 diabetes, by administering to a subject an effective amount of a soluble CTLA4 mutant molecule. One example of a soluble CTLA4 mutant molecule is L104EA29YIg.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.